Description

TheraPsil is a coalition of healthcare professionals, patients, and advocates dedicated to fighting for the rights of Canadians facing end-of-life or illness-related distress to have legal access to therapeutic psychedelics.

Members of the TheraPsil team join ATTMIND for a discussion about their legal argument for access to psilocybin-assisted therapy for the terminally ill here in Canada; the role of psilocybin in helping alleviate the existential suffering that comes during a person's dying time (and thus into talk about life's meaning and its presence or absence in that dying time.

• What access to psilocybin-assisted therapy for terminally ill patients matters
• Our constitutional right to psilocybin
• How psilocybin has helped me with the anxiety of knowing I will die
• The ignorance of the modern medical paradigm around mental health issues
• The modern medical paradigm's focus on suppression rather than healing
• The cultural limitations to undoing bad laws
• Why society more receptive to psychedelics now then they were in the 60s
• Psilocybin revealing the meaning of life through the dissolution of cultural ideologies
• The psychological context of a dying person and why psilocybin-assisted therapy for the terminally ill is helpful in that context
• The negative cultural paradigm we have around death worsens end of life distress and how psilocybin helps
• Dying people are generally on a lot of drugs, how to assess the pharmacological safety of psilocybin in that context
• The complexities of pain management during psilocybin-assisted therapy for the terminally ill
• Advice to palliative nurses based on lessons learned in psilocybin assisted therapy for terminal anxiety
• Pain management reduction of total pain after a psilocybin experience
• The increase of spiritual care in palliative medicine
• What it took for therapsil to succeed in getting access to dying patients in Canada
• Will decriminalization hinder medical access?
• The impact increased access to psilocybin might have for society
• The successful progression of medical science; achieving patient access to psilocybin-assisted therapy for the terminally ill